Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease.

Subjects

Subjects :

Antibodies, Monoclonal, Humanized
Breast Neoplasms metabolism
Female
Humans
Prognosis
Trastuzumab
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents therapeutic use
Breast Neoplasms drug therapy
Receptor, ErbB-2 metabolism

Details

Language :

English

ISSN :

1527-7755

Volume :

28

Issue :

20

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

20479395

Full Text :

https://doi.org/10.1200/JCO.2010.28.2525